VACCINE USAGE: FLULAVAL is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine. FLULAVAL is approved for use in persons aged 6 months and older.

VACCINE DOSAGE: for intramuscular injection only.

  • 6 months through 8 years:
    • not previously vaccinated with influenza vaccine – two doses (0.5-mL each) at least 4 weeks apart.
    • vaccinated with influenza vaccine in a previous season – one or two doses (0.5-mL each).
  • 9 years and older one 0.5-mL dose.

VACCINE INGEDIENTS: thimerosal, a-tocopheryl hydrogen succinate, polysorbate 80, formaldehyde, sodium deoxycholate, ovalbumin.

ADVERSE VACCINE REACTIONS: Guillain-Barre syndrome, syncope (fainting), headache, fatigue, malaise, sore throat, cough, chills, facial swelling, diarrhea, lymphadenopathy, eye pain, photophobia, dysphagia, chest pain, allergies, anaphylaxis, angioedema, rhinitis, laryngitis, cellulitis, arthritis, dizziness, tremors, seizures, limb paralysis, insomnia, bronchospasm, throat tightness.